Connect with us

ICO

ICO Analysis: BlockMason Credit Protocol

Published

on

BlockMason wants to enable anyone to be able to participate in the offering and partaking of credit, through the miracle of blockchain technology.

// -- Discuss and ask questions in our community on Workplace.

With the Credit Protocol, BlockMason has taken the next logical step in the decentralized economy: democratizing the creation of credit. Debt and credit are already extremely powerful financial tools, and now they will be strengthened by the security and flexibility of the blockchain. In fact, because an individual need not own ether in order to draw debt in ether, it is entirely possible to imagine a future in which debts and credits recorded on the Credit Protocol could exceed the total market capitalization of all cryptocurrencies combined, dramatically increasing the scale of the digital economy.

They aim to do this by creating a platform and a protocol for the measuring, establishment, payment, and transfer of credits and debts. While there are platforms like SALT Lending that want to enable people to get credit based on their crypto holdings, it would seem that crypto holdings would be only one asset considered when someone went to get a loan on the Credit Protocol system.

At its most basic level, the Credit Protocol is a system for recording debts and credit between entities on the Ethereum blockchain. One entity sends a debt or credit request to another, and that user then confirms the debt or credit, which is recorded and stored within the Credit Protocol’s smart contract.

The Credit Protocol comes stocked with several Use Case Authority Contracts, or reference contracts, that transactions which take place on the platform are based upon. In a way, we can see how this is a safer and better implementation than would be simply allowing anyone to submit their own contracts for these purposes. There would surely be security issues then.

Use Case Authority Contracts act as a pathway for inputting and settling debts. Because UCACs are user-created, the particular rules that govern recording debt through a UCAC may be optimized to best fit the need of the organization or user employing the Credit Protocol.

What makes the world go around, according to the BlockMason Credit Protocol, is something called CPTs, or Credit Protocol Tokens. CPTs are required to use the platform in several cases. They’re required to purchasing processing power, to open contracts, and the like. BlockMason describes a use case as such:

// -- Become a yearly Platinum Member and save 69 USD and get access to our secret group on Workplace. Click here to change your current membership -- //

Each UCAC requires the operator to “stake” a minimum of one CPT to write debt or credit through that UCAC to the Credit Protocol system. Each CPT possessed by the operator permits the UCAC to process a specified number of transactions per day, a number continuously and dynamically determined by an algorithm within the CP smart contract. Therefore, staking more CPTs allows for greater transaction throughput within the UCAC. Depending on the intended debting system, a user or developer may need to own multiple CPTs to optimally guarantee the UCAC throughput capacity. While users may own fractional tokens, these partial tokens cannot be used to generate transactions. The transactions generated by a single CPT expire 24 hours after generation, at which point the CPT will generate a new set of available transactions.

Now that we have some idea of what the Credit Protocol is, and what its token is for, we can judge ti based on the notion of whether or not we believe that people will want to take loans on this platform. In essence, the truth is that people will take loans on any platform that they can, and the ability to potentially get a loan would be a spur for adoption for plenty of people.

BlockMason already have a working version of their protocol in the form of Fiddy.io, a Mist-browser-based application which allows friends to track debts between each other.

Credit Protocol Token

We think the token’s inherent value of being able to underpin projects like the one pictured above make it a probable good cause for investment. We think that such use cases are endless when specialized, and will pop up all over the place. By building a protocol and allowing a decentralized community to back and power it, BlockMason is essentially just putting down the road upon which all the value-producing cars will travel. But this will be a profitable pursuit, nonetheless.

Distribution

116,158,667 Credit Protocol Tokens are to be issued in total. Around 28 million will be distributed to advisors and developers, another 5 million will be airdropped, and the rest will be sold.

BlockMason

BlockMason are a competent company. We think that they can definitely produce the results desired. They’re selling a total of 90+ million tokens, raising in the neighborhood of 90,000 Ethereum or something like $25 million. We think that with these funds, they’ll be up to the task of completing the job.

The Verdict

In all, we think cryptocurrency is going to need a lot of platforms for lending, microlending, and the like. We think that the Credit Protocol is one of many to come, and that the others which follow may integrate the Credit Protocol or at least build on its ideas.

Risk

  • Could be early, and there could be a period where not enough adoption leads to lessened interest in, and therefore demand for, the token. -2
  • Not novel enough in scope to fundamentally reshape anything. While this might make it lean and profitable, it means that ultimately better mousetraps may soon come along, and with little effort destroy whatever marketshare has been established. -1
  • We fear that this project will be the target of hackers from the get go, and that successful attacks may slow adoption. -1

Growth Potential

  • We mentioned in the article that people are likely to be willing to adopt whatever platform allows them to get funding, regardless of what kind of funding they’re seeking. We think that this will be the case with Credit Protocol, and applications built using the protocol will see serious and widespread adoption. +3.5
  • We think that the traditional financial world will take a heightened interest in projects which use the blockchain for lending, and that there is room for hundreds of such projects. 2.75
  • We like that the token has a required usage within the platform, and that its sale does not appear to be a money grab, as we’ve seen with some. +2
  • We like BlockMason, and have faith that they will carry this project to fruitiion. +1
  • The existence of a demo product in Fiddy.io is encouraging. +1

Disposition

We arrive at a 6.25 for Credit Protocol. We think this is probably one worth getting on board with, though long-term we’re still looking for the unicorn from this field.

Investment Details

You can reserve a presale slot now, or you can wait for the public sale that’s taking place on October 1st. https://blockmason.io/projects/ico/

Important: Never invest (trade with) money you can't afford to comfortably lose. Always do your own research and due diligence before placing a trade. Read our Terms & Conditions here. Trade recommendations and analysis are written by our analysts which might have different opinions. Read my 6 Golden Steps to Financial Freedom here. Best regards, Jonas Borchgrevink.

Rate this post:

Important for improving the service. Please add a comment in the comment field below explaining what you rated and why you gave it that rate. Failed Trade Recommendations should not be rated as that is concidered a failure either way.
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5 (0 votes, average: 0.00 out of 5)
You need to be a registered member to rate this.
Loading...



Feedback or Requests?

1 Comment

1 Comment

  1. tydavis76

    September 15, 2017 at 9:09 pm

    Nice writeup. Agree entirely with the premise that they are laying the groundwork, and that it will be the dapps built on top of the protocol that will drive adoption.

You must be logged in to post a comment Login

Leave a Reply

ICO

ICO Analysis: Zenome

Published

on

Genomics is an interdisciplinary field of science focusing on the structure, function, evolution, mapping, and editing of genomes. A genome is an organism’s complete set of DNA, including all of its genes. In contrast to genetics, which refers to the study of individual genes and their roles in inheritance, genomics aims at the collective characterization and quantification of genes, which direct the production of proteins with the assistance of enzymes and messenger molecules. In turn, proteins make up body structures such as organs and tissues as well as control chemical reactions and carry signals between cells. Genomics also involves the sequencing and analysis of genomes through uses of high throughput DNA sequencing and bioinformatics to assemble and analyze the function and structure of entire genomes. Advances in genomics have triggered a revolution in discovery-based research and systems biology to facilitate understanding of even the most complex biological systems such as the brain.

// -- Discuss and ask questions in our community on Workplace.

The field also includes studies of intragenomic (within the genome) phenomena such as epistasis (effect of one gene on another), pleiotropy (one gene affecting more than one trait), heterosis (hybrid vigour), and other interactions between loci and alleles within the genome. This brief primer on genomics is a good Segway into the Zenome project.

The Zenome Project

We are now able to objectively analyze and observe the behavior of what makes DNA be what it is, exploiting totally new shores on the field, generating an enormous amount of detailed information including patterns and relations between organized molecular systems in an organic entity and biological automation on a whole new level.

According to Nature.com “Two research groups came across the phenomenon independently while studying extracellular vesicles — pieces of cell membranes that pinch off into bubbles and float away from the cells. These vesicles circulate throughout the body, but little is known about their function. The teams, led by neuroscientist Jason Shepherd at the University of Utah in Salt Lake City and cell biologist Vivian Budnik at the University of Massachusetts Medical School in Worcester, looked at mice and flies (Drosophila melanogaster), respectively.”

// -- Become a yearly Platinum Member and save 69 USD and get access to our secret group on Workplace. Click here to change your current membership -- //

Projects like Zenome allow for individual units around the world share their DNA information with a decentralized blockchain based platform, where digital representations of the DNA, under the form of accurate information, are stored, analyzed and exchanged between scientific research foundations, academic labs, hospitals and health technology programs and pharmaceutical research to mention a few.

The Token

ZNA is the native currency of the Zenome Platform, a token based on the Ethereum Network (ERC-20).

The initial pool of tokens released for the presale was 3.2 million ZNA. After the presale reached about 350,000 ZNA, the remaining tokens were burned.

The total number of tokens that will be released at the time of the main token sale is 35 million, of which 25% will be frozen for use as a reward to network participants (for example, for the provision of hard disk space or computing power). Thus, the initial supply was 3.2 million at the moment of the presale. The total supply of the token is 35 million ZNA (including burned tokens), while the max supply will never surpass 35 million tokens. At the same time, the circulating supply will not be more than 75% of the total supply, which is about 26.25 million ZNA.

As for the use of the token, it is a utility token that performs a functional role in the Zenome system, which means it is not just a speculative tool. Inside the Zenome network, a Zenome platform user could use the token to purchase genetic tests and reports, pay for genetic counselors, physicians, and health managers. In fact, you can pay for any service related to your genome, up to and including dating services.

Industrial companies, academia and research sectors will be able to purchase personal genomic data (genetic, medical, behavioral and other) based on real human individuals that are part of the network in exchange for ZNA tokens.  ZNA will be used to build a market for genomic data and any services around it.

Team

The founders of the Zenome Project are Alexey Gorbachev (Research Institute of Physical-Chemical Medicine,  whopreviously worked for Quantum, GenEra and, Institute of Nutrition) and Nikolay Kulemin with a Ph.D. in Bioinformatics from the Moscow Institute of Physics and Technology, department of molecular and biological physics (MIPT). Vladimir Naumov (Genomic Data Scientist) and Sergey Popov (Blockchain Developer) are concluding the core of the Zenome project. The team seems aptly qualified to run a genomics project of this nature.

Verdict

Until recently, the genomics industry was based mostly on speculation, using a substantial amount of animal testing experiments as “information” inputs in order to analyze a biological concept, understand it on a certain degree and determine how it might affect humans. One can readily see how this approach is limiting when it comes to studying human DNA.

Platforms like Zenome can gather “information” regarding the human DNA based on real data collected by physical labs across the globe, which will create certified digital or physical representations of our DNA. We can send this DNA information to the Zenome platform through an application and that would support the fact that this specific information is a catholic example of a specific individual’s DNA.

Zenome aims to provide individuals with the opportunity to control and even monetize their genomic information. One of the project’s core strengths is the promise of establishing equal conditions for drug treatment. It is this interplay that could make Zenome an attractive investment for those willing to learn more about the industry.

Risks

Zenome might sound like a solid project, but if you’re looking at it as an investor and only, you should consider the following facts:

  • The genome market is a brand new field not only when it comes to blockchain but also on a physical scale. There will be a very strict group of organizations that would be keen on purchasing genome databases in the near future. -1
  • A user’s personal genomic information could be exposed to companies that may try to personalize their products based on your data. In other words, there may be significant ethical issues at play in this industry. -3
  • In order to have your genomic data sent to the Zenome platform, you should visit a local lab, authorized by Zenome and experience DNA Sequencing on first hand. This may limit adoption, especially when you compare it to some of the leading DNA ancestral services on the market. (These services send the kit directly to your door and your DNA sample can be sent back via mail.) -2

Growth Opportunity

Zenome plans to hit a market cap of $70bn by the end of 2019, based on their partnerships and analysts. Previous ICO speculations showed us that this number could vary dramatically from the expectations, especially in 2018, where academic, industrial, governmental and banking money are flowing into the blockchain sphere. Below are some of the biggest growth opportunities associated with Zenome:

  • Blockchain was certainly a surprise for all of us and while some are obsessed with the monetary applications and the profitable side, there are literally 4th generation blockchain based projects that are on another level entirely. These projects could unveil the real capabilities of that new technology in almost any possible field we can think of. Zenome appears to be on this level. +3
  • Creating the next generation of drugs that target molecular-level functions is unavoidable. A project like Zenome could help us reach that potential. In other words, the project is well poised to capitalize on partnerships with the pharmaceutical industry, which is highly lucrative. +3
  • Data science technologies in combination with accurate information about human genomics certainly create a whole new concept in the sphere and that is what Zenome is working on. Eventually, health tech will start to integrate  Zenome or similar platforms will have to be established in order to understand better and most important accurately what we are made of, how we can affect our environment and how it affects us. +3
  • The team is led by domain experts in genomics as well as blockchain professionals – a rare combination that could lead to exceptional results. +3

Disposition

The Zenome platform may need some time to create a network of labs, academic partnerships and most important convincing people to do a DNA test is not that simple yet.

We know that we are rolling into an era of machines and humans integrating their intelligence and capabilities into single use cases, but Zenome might sound a little bit “Sci-Fi” for the majority of the people, causing a long curve.

Long-term investors will appreciate its value, realizing the disruption a project like this could bring along when the global health industry realizes the capabilities it offers.

A score of 6 out of 10 is reserved for Zenome, based on present facts.

Investment Details

  • Type: Crowdsale
  • Symbol: ZNA
  • Pre-Sale: Concluded
  • Public Sale: February 1st, 2018
  • Payments Accepted: ETH

Disclaimer: The writer has no position in Zenome at the time of writing.

Featured image courtesy of Shutterstock. 

Important: Never invest (trade with) money you can't afford to comfortably lose. Always do your own research and due diligence before placing a trade. Read our Terms & Conditions here. Trade recommendations and analysis are written by our analysts which might have different opinions. Read my 6 Golden Steps to Financial Freedom here. Best regards, Jonas Borchgrevink.

Rate this post:

Important for improving the service. Please add a comment in the comment field below explaining what you rated and why you gave it that rate. Failed Trade Recommendations should not be rated as that is concidered a failure either way.
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5 (0 votes, average: 0.00 out of 5)
You need to be a registered member to rate this.
Loading...



Feedback or Requests?

Continue Reading

ICO

ICO Analysis: Medicalchain

Published

on

Medicalchain is aiming to disrupt data management in the healthcare industry using decentralization and the blockchain technology.

// -- Discuss and ask questions in our community on Workplace.

Despite the world being in the midst of a data revolution, medical data is yet to catch up with other industries. From centralization, to slow speeds and vulnerable networks, healthcare systems have not evolved along with other industries.

Medicalchain is solving four significant issues with the current state of healthcare data storage.

  • Interoperability: Health data contained in legacy systems is fragmented because of varying systems and formats. There is no single version of truth which can be used and accessed by all the stakeholders.
  • Security and Fraud: Sensitive information about patients is stored in centralized legacy servers. WannaCry attack crippled the NHS with an attack on more than 230K computer systems. Medical data is sold on the dark web for almost 10x the price of credit card info.
  • Data storage: Medical data is usually controlled by a single entity which results in high dependency on that system. NHS recently lost the medical records of around 700K patients putting their health at risk.
  • Privacy control: Patients have no control over who uses and accesses their medical information.

Medicalchain’s decentralized platform enables secure, fast and transparent exchange and usage of medical data using the blockchain technology. The platform is built using a dual blockchain structure. The first blockchain controls access to health records and is built using Hyperledger Fabric. The second blockchain is powered by an ERC20 token on Ethereum and underlies all the applications and services for the platform.

// -- Become a yearly Platinum Member and save 69 USD and get access to our secret group on Workplace. Click here to change your current membership -- //

Hyperledger fabric allows access control and multiple layers of permissions which is ideal for the privacy control use case. Only the patients can access their medical data while blockchain makes it immutable to hacks and breaches.

Medicalchain is not just a platform to store and access medical data but provides an infrastructure for digital health application and services to be built on top of the healthcare database. The company is currently developing two applications to work alongside the platform: a doctor-to-patient telemedicine application and a health data marketplace. Going ahead, Medicalchain aims to serve as an ecosystem for decentralized healthcare applications. A closed beta platform will be launched in February of this year.

Token

The ERC20 MedToken will be used to access and pay for applications built on top of the Medicalchain data. When conducting telemedicine consultations (using the Telemedicine application), patients will pay the doctors using MedTokens.

Pharmaceutical organizations will pay the patients in the form of MedTokens if the patients provide them access to his medical history using the marketplace application.
Users will use MedTokens for a variety of other applications and services that will be developed on Medicalchain’s platform.

Team

Co-founder Dr. Abdullah Albeyatti created an application called Discharge Summary in 2016 to generate accurate medical reports on patients, before they are discharged. He created these frameworks to create standardization in medical reports. Discharge Summary is being used in 3 hospitals in the UK. Discharge Summary is a very small component of Medicalchain, and contrary to many claims, it would be inappropriate to suggest that Medicalchain is being tested in 3 hospitals.

The other Co-founder Mo Tayeb is a tech entrepreneur and has previously founded technology, finance, and e-commerce companies.

There are 13 members in the team with extensive experience in healthcare and tech.

Medicalchain has eight advisors which include healthcare professionals and blockchain specialists.

Verdict

Medical error is the third leading cause of death in the United States; add to it the woes faced by NHS in 2017, we can conclude that Medicalchain is working on a real problem which needs immediate solutions. The team looks solid with a mix of both healthcare and technology.
Medicalchain also scores well on the hype factor, with more than 10K members on the Telegram group a couple of weeks before the ICO.
But as with any industry with solid blockchain use case, there are many current and upcoming projects competing with Medicalchain.

Medicalchain vs. competition?
The most well-known project in this space is Patientory. Patientory differs from Medicalchain in 2 major aspects. Patientory is primarily focused in the US, while Medicalchain has global ambitions. After initial testing in the US and the UK, Medicalchain will expand in other geographies in this year itself. Another major differentiator is that Medicalchain follows a bottom-up approach, where they plan to integrate patients and doctors onto the platform and then make the platform functional using the Telemedicine application. Patientory follows a top-down approach and is trying to partner with establishments, hospitals, healthcare organizations. We have a favorable view of the bottom-up approach, as it makes the project less dependent on partnerships and can be readily operational.

Medibloc is another platform operating in the same sector. Medibloc is based on Qtum while Medicalchain’s data layer is based on hyperledger fabric, which we feel is more suitable for this use case. We also think Medicalchain’s team more capable than either of these projects.

Overall Medicalchain is a good project on the conceptual level, but some concerns start to emerge once you think about executing it on scale. We will discuss some of these concerns in the Risks section.

Risks

  • The team will have to interact with multiple entities including the doctors, patients, pharmacies, insurers.
    Bringing all these entities on board and convincing them about the potential benefits won’t be an easy task. -2
  • Interacting with the regulatory authorities of each region will have its own difficulties. Each geography has its specific laws and regulations when it comes to medical data. E.g., in the US, the patients do not necessarily own their medical data, the hospitals and the clinicians have the right over it. The UK has a central healthcare database, but Medicalchain will need to extract data from the UK’s central servers which are based on subpar technology. -3
  • Medicalchain is expected to face significant competition in the future. Tech giants like IBM are actively exploring blockchain solutions for the healthcare industry. IBM recently collaborated with major insurers in India for blockchain solutions. -1

Growth Potential

  • The project fares better regarding the team, roadmap, and vision against the existing competition. Co-founder Dr. Abdullah Albeyatti has been working in this direction since 2016. +5
  • There is a significant growth potential for blockchain solutions in the healthcare industry, especially in the Healthcare data segment. Considering the issues that NHS had to face in the past year, UK seems like ideal geography to begin operations. +4
  • Medicalchain is also creating an application layer to build medical applications. The Telemedicine application and the health data marketplace differentiates it from other similar services and will create a pathway for future healthcare applications to be launched on the platform. +3

Disposition

We arrive at a score of +6 for Medicalchain. The score captures the growth potential of the project but also incorporates some execution level concerns.

Investment Details

  • Token Type: Utility
  • Platform: Ethereum
  • Symbol: MEDTOKEN
  • Pre-sale: Sold out
  • Public sale: 1 February 2018
  • Initial value: 1 MEDTOKEN = 0.25 USD
  • Hard cap: 24,000,000 USD
  • Total Tokens: 500,000,000
  • Available for Token Sale: 35%
  • Website link: http://medicalchain.com/
  • Jurisdictions Barred from Participating: U.S

Featured image courtesy of Shutterstock.

Important: Never invest (trade with) money you can't afford to comfortably lose. Always do your own research and due diligence before placing a trade. Read our Terms & Conditions here. Trade recommendations and analysis are written by our analysts which might have different opinions. Read my 6 Golden Steps to Financial Freedom here. Best regards, Jonas Borchgrevink.

Rate this post:

Important for improving the service. Please add a comment in the comment field below explaining what you rated and why you gave it that rate. Failed Trade Recommendations should not be rated as that is concidered a failure either way.
2 votes, average: 5.00 out of 52 votes, average: 5.00 out of 52 votes, average: 5.00 out of 52 votes, average: 5.00 out of 52 votes, average: 5.00 out of 5 (2 votes, average: 5.00 out of 5)
You need to be a registered member to rate this.
Loading...



Feedback or Requests?

Continue Reading

ICO

ICO Analysis: Electrify.Asia

Published

on

Electricity

According to the Globalist, “developing countries in Asia are now entering their most energy-intensive phase of development. In line with rising living standards, they increase their consumption for industrialization, infrastructure, transportation and development.”

// -- Discuss and ask questions in our community on Workplace.

Analysts expect that by 2030, half of the demand in energy markets will come from China and India – the other countries in Asia will also make up significant percentage of demand. With this in mind, Asian countries will need to provide consumers with energy security at affordable prices. If they don’t, they won’t be able to meet the burgeoning demand of their rapidly growing populations. However, energy security at affordable prices is very difficult to accomplish.

In light of this, Electrify.Asia is looking to capitalize on Asia’s growing energy security needs. The company aims to “enable the decentralization of power production and bring the power of choice to the consumer.” Essentially, Electrify.Asia is using blockchain technology to disrupt the massive energy industry in Asia by providing both transparency and lower prices to consumers.

Token:

The Electrify.Asia token (ELEC) will be implemented using the Ethereum ERC20. ELEC holders generate value from the token in three ways: (1) loyalty rewards for consumers, (2) the ability to pay transaction fees, and (3) the ability to pay listing deposits for access to Electrify.Asia’s ecosystem.

// -- Become a yearly Platinum Member and save 69 USD and get access to our secret group on Workplace. Click here to change your current membership -- //

According to the white paper, 54% of the funds raised will go towards development, technology and research, 20% towards staffing (HR), 10% towards legal and accounting, 10% towards business development and partnerships, and the rest of the pot (6%) towards operations.

ELEC tokens are valued at $0.08 per 1 ELEC token. The total amount of tokens to be sold is capped at 375,000,000 ELEC. However, the total token supply will capped at 750,000,000 ELEC. The token distribution is as follows: 50% for token sale, 18.4% for team and future members (vesting: 50% at each 6 month interval), 9.0% for advisors and partners, 18.5% for treasury and community development, and 4.1% for airdrop to the community.

The company has not yet stated its intention to list the ELEC tokens on any major crypto exchanges.  

Team:

Electrify.Asia’s core team consists of two senior executives, three business development professionals, two developers, and an operations professional. As compared with the majority of ICOs, Electrify.Asia has a relatively solid team.  

The company’s CEO, Julius Tan, was previously a Solar Research Engineer at the National University of Singapore and an energy trader at an unspecified energy company. Tan has also held a variety of positions at the Singapore Economic Development Board, Standard Chartered Bank and Schlumberger. Additionally, Tan received a BA and MA in Engineering at the University of Cambridge. The company’s COO, Martin Lim, is a 20+ year veteran of the mass communication industry. Lim has worked at a variety of companies including: InMobi, HTC, StarMedia, and Sunseap Energy.

The company’s advisors include the CEO of Omise, a VC executive, a solar executive, an AI/ML researcher, a software engineer, and a compliance executive.

Verdict:

Electrify.Asia presents a highly speculative buying opportunity for investors interested in long-term capital appreciation.  

Energy security is the foundation for developing Asia’s economic transformation, prosperity and development. By decentralizing energy markets across Asia, the company will provide a much needed reform that will lower costs and bring energy security to many emerging market consumers.

However, the primary concern is market adoption across developing Asia. While Electrify.Asia’s technology has a strong potential to be adopted across the developed countries in Asia-Pacific (Japan, Singapore, South Korea and Australia), developing countries across Asia are likely many years away from accepting the technology that the company offers.

Basically, there’s a lot of risk for the company in the developing countries across Asia. In contrast, developed countries in the Asia-Pacific region will likely be open to using the technology. While Electrify.Asia has a strong chance of being successful across developed markets, the company will face many tough hurdles in expanding into some of their target markets (such as: Philippines, Thailand, Vietnam, Thailand, China, India, etc.).

Risks:

Scaling across Asia is a long and costly process. Each country requires localization, on-the-ground teams, and extensive regulatory compliance. The company’s team may be underestimating the total time and cost of their overall strategy – it’s likely to be much greater than expected. -2

Energy markets in South East Asia are highly regulated and still have infrastructure gaps. While Singapore may be the first country in the region to liberalize its energy market, developing countries (such as: Philippines, Thailand, Malaysia, Indonesia, etc.) still lack the infrastructure to be able to do so. Meaning, the company’s technology may be too early for their target markets. -2

Beyond technology risk, market adoption risk runs high for Electrify.Asia. Unless governments across Asia liberalize their energy markets, there is no incentive for energy companies to adopt the added expense of using Electrify.Asia’s platform/ecosystem. -1

Localization in emerging markets will require the company to be able to accept over-the-counter cash payments – many emerging market consumers do not use or have access to credit cards. This will require many strategic partnerships across Asia and is not mentioned as a strategy in the white paper. -1

Growth Opportunity:

Provided the company can successfully scale across Asia, the company will benefit from a large and diverse customer base that is increasingly becoming wealthier and larger (relative to the anaemic growth in the West). With this in mind, global spending by the middle class is expected to reach $35 trillion by 2020 and $56 trillion by 2030 – over 80% of this growth is coming from Asia. Asia’s emerging middle class is shifting the world’s consumer spending paradigm (they’re demanding higher transparency) – Electrify.Asia will be a prime beneficiary of this shift, since energy markets are currently opaque. +4

According to the Asian Development Bank, “annual energy expenditure in Asia is expected to grow from US$700 billion to $US1.6 trillion by 2035.” The company stands to benefit from a large, rapidly growing market that is characterized by significant greenfield opportunities and long-term growth potential. +4  

As developed markets in Asia liberalize their energy markets, Electrify.Asia doesn’t have any real competition to tend with. Basically, the company will benefit from a significant first-mover advantage. +4

Disposition:

Electrify.Asia has a great vision and a solid team, however the company’s technology may be too early for many developing countries across Asia. Provided the company can shift focus to solely the developed countries in the Asia-Pacific region (Japan, South Korea, Australia and Singapore), the company will have a strong potential to become successful.

Beyond technology risk, execution risk and the amount of capital needed for large-scale geographical expansion is being understated by the company – a hard cap of $30M isn’t nearly enough. Additionally, there’s a lot of unanswered questions related to the company’s business development model and approach to strategic partnerships.

Overall, even though technology, market adoption, and execution risk runs high, the company still stands a chance to be the dominant player in the newly liberalized energy markets across developed Asia.

Against this backdrop, we believe that a score of 6 out of 10 is warranted.

Investment Details:

  • Type: Crowdsale
  • Symbol: ELEC
  • Pre-Sale: N/A
  • Public Sale: February 23, 2018
  • Payments Accepted: ETH

Disclaimer: The writer has no position in Electrify.Asia at the time of writing.

Important: Never invest (trade with) money you can't afford to comfortably lose. Always do your own research and due diligence before placing a trade. Read our Terms & Conditions here. Trade recommendations and analysis are written by our analysts which might have different opinions. Read my 6 Golden Steps to Financial Freedom here. Best regards, Jonas Borchgrevink.

Rate this post:

Important for improving the service. Please add a comment in the comment field below explaining what you rated and why you gave it that rate. Failed Trade Recommendations should not be rated as that is concidered a failure either way.
4 votes, average: 1.75 out of 54 votes, average: 1.75 out of 54 votes, average: 1.75 out of 54 votes, average: 1.75 out of 54 votes, average: 1.75 out of 5 (4 votes, average: 1.75 out of 5)
You need to be a registered member to rate this.
Loading...



Feedback or Requests?

Continue Reading

Recent Comments

Recent Posts

A part of CCN

Hacked.com is Neutral and Unbiased

Hacked.com and its team members have pledged to reject any form of advertisement or sponsorships from 3rd parties. We will always be neutral and we strive towards a fully unbiased view on all topics. Whenever an author has a conflicting interest, that should be clearly stated in the post itself with a disclaimer. If you suspect that one of our team members are biased, please notify me immediately at jonas.borchgrevink(at)hacked.com.

Trending